Global Healthcare | 28 Deals, Investments & Transactions | Week 44 – Oct 2016 https://t.co/3negYzdvXZ — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
“Global Healthcare | 28 Deals, Investments & Transactions | Week 44 – Oct 2016” https://t.co/Li5A2doR2n by @ThePropellGroup on @LinkedIn — The Propell Group [...]
Singapore-based Jubilee Capital hits first close for $100m tech-startup fund: https://t.co/u2MX49wEzz — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
Future Of Cancer Treatment: Immunotherapy Startups Take Lion’s Share of Oncology Deals https://t.co/h9Eip0JN9h — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
Here’s who Goldman Sachs thinks you should pay attention to in tech this year – Recode https://t.co/IIHXPsH1EH — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
Celgene, Novartis, Pfizer, Google Back Startups Attacking Cancer https://t.co/75dGXcKl6S — The Propell Group (@ThePropellGroup) November 7, 2016 #healthtech
The Economist | Private Equity: The barbarian establishment https://t.co/CIZp4GzTHe — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
The Economist | Business in America: Float like a butterfly https://t.co/va0wmG80by — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
Microsoft says it will solve cancer in the next 10 years https://t.co/n38zPJLZmJ — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech
Making the microbiome part of precision medicine https://t.co/83cYFGo5wF — The Propell Group (@ThePropellGroup) November 6, 2016 #healthtech